Julie Vetalice, Author at ORTHOWORLD

DePuy Synthes/JNJ Acquiring BioMedical Enterprises

Competitive Landscape Mergers & Acquisitions

DePuy Orthopaedics has acquired BioMedical Enterprises, a manufacturer of Nitinol orthopaedic implants for small bone fixation to treat bunions, hammertoes, hand/wrist deformities, etc.

May 10, 2016

SpineGuard Launching PediGuard Threaded DSG Device

ORTHOFLASH Spine

SpineGuard announced commercial launch of its PediGuard Threaded DSG™ (Dynamic Surgical Guidance) device.

May 10, 2016

Histogenics Acquires Rights to NeoCart for the Japanese Market

Competitive Landscape Mergers & Acquisitions

Histogenics acquired development and commercialization rights to NeoCart® for the Japanese market from its partner, Purpose Co. NeoCart autologous cell therapy is designed to treat knee cartilage defects.

May 10, 2016

Results from Study of Moximed’s Atlas Knee

Joint Replacement ORTHOFLASH

Study results suggest that Moximed’s Atlas™ knee provided rapid, clinically-effective pain relief for patients with early knee OA in the pre-arthroplasty disease stage.

May 09, 2016

Orthocell Gains Approval for Collagen Scaffold Study

Orthobiologics ORTHOFLASH

Orthocell was granted ethical approval in Australia for a clinical study of a microfracture technique using the Celgro SMRT Graft collagen scaffold.

May 04, 2016

Spinal Simplicity Gains Investor Support from Nueterra

Investments The Numbers

Spinal Simplicity closed a financing round with an investment from Nueterra Capital. Funds will support U.S. launch of the Minuteman fusion device to treat low back pain.

May 03, 2016

Medtronic Presents Results of 7-year Study on 2-level Prestige LP Cervical Disc

ORTHOFLASH Spine

Seven-year follow-up data demonstrated favorable clinical outcomes and patient satisfaction for Medtronic’s 2-level Prestige LP™ cervical disc vs. 2-level ACDF.

May 03, 2016

MEDTECH Announces First U.S. ROSA Spine Surgery

ORTHOFLASH Robotics/Tech

MEDTECH announced the first procedure using the ROSA™ Spine robot in the U.S.

May 03, 2016

Bone Therapeutics Completes Recruitment in ALLOB Phase IIA Spinal Fusion Study

Orthobiologics ORTHOFLASH

Bone Therapeutics completed recruitment for its ALLOB® allogeneic cell therapy Phase IIA spinal fusion study. The company will extend the trial to assess early onset of bone formation and fusion.

May 03, 2016

SI-BONE’s iFuse Surpasses 20,000 Surgeries

ORTHOFLASH Spine

Since launch in 2009, SI-BONE’s iFuse Implant System® has been used in >20,000 procedures worldwide. The product was recently launched in Australia and New Zealand.

May 03, 2016

Get the ORTHOWORLD Newsletter!

Contact Us